PSDV - pSivida Limited Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited

PSDV 1.220

+14.0%

Mar 29 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: John McCarthy	1/26/2010 6:06:21 PM
	of 421

New Presentation phx.corporate-ir.net phx.corporate-ir.net Page 12 of 29 --------------------------------- Iluvien 2 Year Results: Percentage of patients ggaaiinniinngg >>115 lleetttteerrss Page 16 of 29 --------------------------------- Low dose vs Sham Patients with Vision > 49 letters --------------------------------- 21.1 % Iluvien patients gained >15 letters 11.8% sham patients gained > 15 letters Statistically Significant (p = 0.03) Low Dose vs Sham Patients with vision < 50 letters --------------------------------- 46.1% Iluvien patients gained > 15 letters 28.6% sham patients gained > 15 letters Statistically Significant (p = 0.04) Page 25 of 29 --------------------------------- Shares Outstanding: 18 million Warrants ($7 avg. price): 13 million Major Shareholder: Pfizer 1.9 million Page 6 o 29 --------------------------------- More than 10 million Americans aged 40+ suffer from potentially blinding back of the eye diseases More than 2 million Americans have been diagnosed with AMD and cases have risen 25% from 2002-2008 Diabetic retinopathy affects more than 4.4 million Americans due to the increased incidence of diabetes and the number of cases is rapidly increasing 2.3 million Americans have glaucoma and an estimated 2 million more are undiagnosed Eye disease can be devastating to an individual and their caregivers Page 10 o 29 --------------------------------- A $1+ billion market opportunity The leading cause of vision loss for Americans under 65 Over 1,000,000 treatable cases in the U.S. Current therapy – Laser Treatments No FDA Approved drug therapy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next